Biofrontera Inc. Interest Expense Nonoperating
Biofrontera Inc. (BFRI) reported Interest Expense Nonoperating of $120.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2025-05-15
- Biofrontera Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $120.00K, a 91.56% decline year-over-year.
- Biofrontera Inc. interest expense nonoperating for the quarter ending 2024-03-31 was $1.42M.
| Period end | Interest Expense Nonoperating 3 month |
|---|---|
| 2025-03-31 | $120.00K 10-Q · filed 2025-05-15 |
| 2024-03-31 | $1.42M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |